We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prise en charge du mélanome uvéal en oncologie médicale en 2020.
- Authors
Piperno-Neumann, Sophie; Mariani, Pascale; Servois, Vincent; Pierron, Gaelle; Lumbroso-Rouic, Livia; Matet, Alexandre; Rodrigues, Manuel; Cassoux, Nathalie
- Abstract
Uveal melanoma is a rare subtype of melanoma, intrinsically different from cutaneous melanoma. Despite optimal therapeutic management allowing local control of the primary ocular tumor, 20 to 50% of patients develop metastases, mainly localized to the liver, with a poor prognosis and a 12-month median survival from the diagnosis of the metastatic disease. There is a lack of effective treatments in the metastatic setting, and dedicated strategies and trials for uveal melanoma patients are needed, based on identification of new targets and specific preclinical findings.
- Subjects
SURVIVAL rate; MELANOMA; OCULAR tumors; PROGNOSIS; DIAGNOSIS; LIVER
- Publication
Oncologie (Tech Science Press), 2020, Vol 22, Issue 4, p203
- ISSN
1292-3818
- Publication type
Article
- DOI
10.32604/oncologie.2020.014102